Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 2
1954 1
1955 1
1956 1
1961 5
1962 6
1963 6
1964 6
1965 22
1966 12
1967 11
1968 4
1969 26
1970 16
1971 13
1972 14
1973 27
1974 29
1975 32
1976 30
1977 36
1978 33
1979 29
1980 40
1981 30
1982 39
1983 51
1984 57
1985 73
1986 59
1987 69
1988 86
1989 81
1990 91
1991 73
1992 78
1993 77
1994 83
1995 98
1996 114
1997 115
1998 132
1999 124
2000 134
2001 151
2002 153
2003 174
2004 167
2005 182
2006 188
2007 192
2008 206
2009 219
2010 250
2011 258
2012 320
2013 281
2014 266
2015 244
2016 278
2017 309
2018 325
2019 353
2020 369
2021 398
2022 410
2023 351
2024 348
2025 363
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,074 results

Results by year

Filters applied: . Clear all
Page 1
Hsa-miR-155-5p expression in primary breast tissue may have the potential for prediction of breast cancer brain recurrence: results from the multi-institutional exploratory cohort study.
Koyama Y, Muguruma M, Horimoto Y, Narui K, Yamada A, Yamada K, Yamamoto S, Orihara S, Kaise H, Kogure A, Yoshioka Y, Ochiya T, Ishikawa T. Koyama Y, et al. Among authors: ishikawa t. Breast Cancer Res. 2025 Sep 29;27(1):169. doi: 10.1186/s13058-025-02123-5. Breast Cancer Res. 2025. PMID: 41024045 Free PMC article.
Response.
Yamamura T, Nakamura M, Hiramatsu M, Uchida G, Yamada K, Kuno T, Maeda K, Sawada T, Ishikawa E, Hirose T, Ishikawa T, Furukawa K, Honda T, Kawashima H. Yamamura T, et al. Among authors: ishikawa t. Gastrointest Endosc. 2025 Nov 11:S0016-5107(25)02069-3. doi: 10.1016/j.gie.2025.09.051. Online ahead of print. Gastrointest Endosc. 2025. PMID: 41324528 No abstract available.
Response.
Yamamura T, Nakamura M, Hiramatsu M, Uchida G, Yamada K, Kuno T, Maeda K, Sawada T, Ishikawa E, Hirose T, Ishikawa T, Furukawa K, Honda T, Kawashima H. Yamamura T, et al. Among authors: ishikawa t. Gastrointest Endosc. 2025 Nov 10:S0016-5107(25)02072-3. doi: 10.1016/j.gie.2025.10.002. Online ahead of print. Gastrointest Endosc. 2025. PMID: 41217331 No abstract available.
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial.
Watanabe H, Natsuaki M, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Kimura T, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. Watanabe H, et al. Among authors: ishikawa t. Eur Heart J. 2024 Dec 16;45(47):5042-5054. doi: 10.1093/eurheartj/ehae617. Eur Heart J. 2024. PMID: 39215959 Clinical Trial.
8,074 results